Market Insights Health OTC Pharmaceuticals

Analgesics - GCC

In 2024, the revenue in the Analgesics market in the GCC amounts to US$0.58bn.
It is projected to experience an annual growth rate of 5.55% (CAGR 2024-2029).
When comparing globally, the in the United States generates the highest revenue in this market, reaching US$7,243.00m in 2024.
In terms of per capita figures, the revenue generated per person in the GCC is US$9.61 in 2024.
The demand for analgesics in the GCC market is driven by the high prevalence of chronic pain conditions and a growing aging population.

Key regions: Canada, United States, United Kingdom, Australia, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in GCC is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications.

Customer preferences: Customers in the GCC region have shown a growing preference for over-the-counter analgesics due to their convenience and accessibility. Over-the-counter medications allow customers to quickly and easily alleviate pain without the need for a prescription or a visit to the doctor. This has led to an increase in self-medication practices among consumers in the region. Additionally, customers in the GCC are increasingly becoming health-conscious and are actively seeking out products that provide quick and effective pain relief.

Trends in the market: One of the key trends in the Analgesics market in GCC is the growing demand for natural and herbal pain relief products. Customers are becoming more conscious about the ingredients in the products they consume and are opting for natural alternatives to traditional analgesics. This trend is driven by a desire for safer and more sustainable options, as well as a growing awareness of the potential side effects of certain chemical-based medications.Another trend in the market is the increasing availability of analgesics in different formats and formulations. Manufacturers are constantly innovating and introducing new products to cater to the diverse needs and preferences of customers. This includes the development of fast-acting pain relief solutions, such as gels and sprays, as well as extended-release formulations for long-lasting relief. These innovations have been well-received by customers in the GCC, who are always on the lookout for more effective and convenient options.

Local special circumstances: The GCC region has a high prevalence of chronic conditions such as arthritis and back pain, which contribute to the demand for analgesics. The hot climate in the region also leads to an increase in muscle and joint pain, further driving the need for pain relief medications. Moreover, the GCC countries have a large expatriate population, who often rely on over-the-counter analgesics for self-medication due to the limited availability of healthcare services.

Underlying macroeconomic factors: The growing population and increasing disposable income in the GCC region are key macroeconomic factors driving the growth of the Analgesics market. As the population continues to expand, so does the demand for healthcare products and services, including pain relief medications. Additionally, the rising disposable income levels in the region have enabled customers to afford and purchase analgesics more frequently.In conclusion, the Analgesics market in GCC is witnessing steady growth due to the increasing customer preference for over-the-counter pain relief medications. The market is characterized by a growing demand for natural and herbal products, as well as a wide variety of formats and formulations. The high prevalence of chronic conditions, the hot climate, and the large expatriate population in the region contribute to the demand for analgesics. The growing population and increasing disposable income in the GCC are underlying macroeconomic factors that are driving the market growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.